Join
Live feed
·
PRReleasevia Quantisnow
Ascentage Pharma Group International logo

Ascentage Pharma To Present Data from Two Clinical Studies at 2025 ASCO Annual Meeting, Including Oral Presentation on Its Key Assets Lisaftoclax and Alrizomadlin

ByQuantisnow·Wall Street's wire, on your screen.
AAPG· Ascentage Pharma Group International
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AAPG (Ascentage Pharma Group International) and more on Quantisnow.

Ascentage Pharma To Present Data from Two Clinical Studies at 2025 ASCO Annual Meeting, Including Oral Presentation on Its Key Assets Lisaftoclax and Alrizomadlin | Quantisnow